Denovium and Maxygen Enter Into Partnership in Artificial Intelligence

Biopharma

DEINOVE is now ready to start Phase II clinical trial for its antibiotic compound DNV3837

Having reached a sufficient number of clinical centers, Phase II clinical trial testing the antibiotic candidate DNV3837 in Clostridioides1 (Clostridium) difficile infections will start this summer in the United States...

Renaissance BioScience files PCT Patent Application for Yeast-based RNA Bioactive Molecule Production and Delivery Technology Platform

Lonza chooses Synpromics’ novel inducible promoter platform to manufacture biopharmaceuticals

Edinburgh, UK, 16th May 2019 / Synpromics Ltd, the leader in gene control, and Lonza Pharma & Biotech announce a partnership for the commercialisation of a number of inducible promoters to improve the manufacturing...

Vedanta Biosciences Closes Extended $45.5 Million Series C Financing

Oxford Genetics and Cell and Gene Therapy Catapult collaborate to develop scalable gene therapy manufacturing processes

Agilent Announces Unique Portfolio to Advance Immunotherapy

C3J Therapeutics and AmpliPhi Biosciences Announce Successful Completion of Merger and Formation of Bacteriophage Company Armata Pharmaceuticals, Inc.

Beam Therapeutics Presents Data on Multiplex Base Editing for Engineered CAR-T Cells at American Society of Gene and Cell Therapy 22nd Annual Meeting

Thermo Fisher Scientific Completes Acquisition of Brammer Bio

Precigen Opens Gene and Cell Therapy Manufacturing Facility in Germantown, Maryland

NAVAN Closes Seed Funding Round

Poseida Therapeutics Raises $142 Million in Series C Financing

Autolus Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares

Biomica Initiates Pre-Clinical Studies in its Immuno-Oncology Program

Novel antibiotics: DEINOVE signs an agreement with the Institut Pasteur to explore the potential of new targeted strains